GlassScriptPhysician profile
John C Garber
NPI 1972528339
$1,525.69
in general payments reported to CMS, 2019-2025
17 companies · $190 in 2025
The $190 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $149 · 2022: $486 · 2023: $419 · 2024: $282 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $890.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $466.03 | 2021-2024 | Micra, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $238.70 | 2021-2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $143.33 | 2022-2025 | Lifevest |
| Abbott Laboratories | $138.87 | 2023-2025 | Ensite, Tacticath Ablation Catheter, Sensor Enabled, Mitraclip |
| Astrazeneca Pharmaceuticals LP | $90.88 | 2022-2024 | Wainua |
| Pfizer INC. | $73.99 | 2022-2024 | |
| Stryker Corporation | $58.47 | 2023-2024 | N/A |
| Novartis Pharmaceuticals Corporation | $51.70 | 2023-2024 | |
| Abiomed | $51.14 | 2024-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $49.90 | 2022 | |
| Novo Nordisk INC | $41.92 | 2023-2024 | Ozempic, Rybelsus |
| Lantheus Medical Imaging, INC. | $28.87 | 2025 | |
| Scpharmaceuticals INC. | $25.72 | 2023 | |
| Livanova USA, INC. | $23.83 | 2023 | Tandemlife |
| Boston Scientific Corporation | $16.74 | 2025 | Avvigo Guidance System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $13.15 | 2023 | Xarelto |
| Teleflex LLC | $12.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Garber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.